Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3
Related Posts
Zhang YF, Chang CE, Varghese TK Jr, Tao R, Hashibe M. Increased risks of type II diabetes among older Asian, Native Hawaiian, and Pacific Islander[...]
Chowdhury K, Das D, Huang M. Advancing the Metabolic Dysfunction-Associated Steatotic Liver Disease Proteome: A Post-Translational Outlook. Genes (Basel). 2025 Mar 12;16(3):334. doi: 10.3390/genes16030334. PMID:[...]
Lyu Y, Tong S, Huang W, Ma Y, Zeng R, Jiang R, Luo R, Leung FW, Lian Q, Sha W, Chen H. Observational, causal relationship[...]